From: Sodium ion channel mutations in glioblastoma patients correlate with shorter survival
Tumor ID | Patient age (years) | Sex | Pathology | Recurrent GBM | Secondary GBM | Prior radiation therapy | Prior chemotherapy | Survival after tumor sample obtained (Days) | Sample type | Sodium channel mutations | Potassium channel mutations | Calcium channel mutations |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Br02X | 39 | M | GBM | No | No | No | No | Unknown | XG | Yes | No | Yes |
Br03X | 44 | M | GBM | No | No | No | No | 422 | XG | Yes | Yes | No |
Br04X | 45 | F | GBM | Yes | No | NA | NA | Unknown | XG | No | No | No |
Br05X | 41 | M | GBM | No | No | No | No | 563 | XG | No | No | Yes |
Br06X | 11 | M | GBM | No | No | No | No | 986 | XG | No | No | No |
Br07X | 45 | M | GBM | No | No | No | No | 350 | XG | Yes | No | Yes |
Br08X | 54 | M | HGG | No | No | No | No | 384 | XG | No | Yes | No |
Br09P | 51 | M | GBM | No | No | No | No | 588 | PT | Yes | Yes | Yes |
Br10P* | 30 | F | GBM | No | No | No | No | 813 | PT | No | No | Yes |
Br11P* | 32 | M | GBM | No | No | No | No | 1502 | PT | No | Yes | No |
Br12P* | 31 | M | GBM | No | No | No | No | 566 | PT | No | No | Yes |
Br13X | 59 | F | GBM | No | No | No | No | 174 | XG | Yes | Yes | Yes |
Br14X | 61 | F | GBM | No | No | No | No | Unknown | XG | No | Yes | Yes |
Br15X | 61 | M | GBM | No | No | No | No | 56 | XG | Yes | No | Yes |
Br16X | 63 | M | GBM | No | No | No | No | Unknown | XG | Yes | No | Yes |
Br17X | 63 | M | GBM | No | No | No | No | 964 | XG | No | Yes | Yes |
Br20P | 77 | F | GBM | No | No | No | No | 122 | PT | Yes | Yes | Yes |
Br23X | 78 | F | GBM | No | No | No | No | 16 | XG | Yes | No | No |
Br25X | 45 | M | GBM | No | No | No | No | 48 | XG | Yes | No | No |
Br26X | 66 | F | GBM | No | No | No | No | 61 | XG | No | Yes | No |
Br29P | 42 | F | HGG | Yes | NA | NA | NA | Unknown | PT | Yes | Yes | No |